Shockwave Javelin

Move calcium modification forward with our first-of-its-kind Forward Intravascular Lithotripsy (IVL) Platform. Crack calcium to enable further treatment and expand treatment options across calcified peripheral lesions.

Javelin Case Reviews Download Tech Sheet
Product image of the Shockwave generator and Shockwave Javelin Peripheral IVL catheter
Product image of the Shockwave generator and Shockwave Javelin Peripheral IVL catheter

Shockwave Javelin Peripheral logo

Shockwave Javelin: Crack Calcium to Enable Further Treatment

Our FORWARD IVL platform is designed to deliver energy beyond the tip of the catheter to modify calcium and keep procedures moving forward.

  • First-of-its-kind Forward IVL platform cracks calcium beyond the tip

    With a single distal emitter situated in the tip of the catheter, the delivery of spherical energy enables cracking of calcium in front of the catheter.*

  • Consistent ultrasonic acoustic output similar to Balloon IVL platform

    This novel device leverages robust clinical data around Shockwave’s unique waveform highlighting the safety and efficacy of Shockwave IVL’s mechanism of action.†, 1, 2, 3, 4

  • Expands treatment options across calcified peripheral lesions

    By combining the Forward IVL platform with the established Shockwave IVL mechanism of action, it broadens where IVL can be applied across peripheral anatomy.
digital rendering of shockwave javelin catheter and device tip with labels

How to Use Shockwave Javelin

  • Illustrated image demonstrating how the Shockwave Javelin Peripheral IVL Catheter is delivered to a calcified lesion within the vasculature, without the need for a balloon or inflation

    Step One

    Deliver Shockwave Javelin to the calcified lesion – no balloon, no inflation necessary
  • Illustrated image demonstrating how gentle forward pressure is applied while the Shockwave Javelin Peripheral IVL Catheter generates sonic pressure waves to crack calcified lesions ahead of the catheter within the vasculature

    Step Two

    Apply gentle forward pressure while generating sonic pressure waves to crack calcium ahead of the catheter.
  • Illustrated image demonstrating how the Shockwave Javelin Peripheral IVL Catheter advances through the vasculature and crosses a previously uncrossable calcified lesion

    Step Three

    Continue IVL delivery to achieve adequate calcium modification and facilitate subsequent therapy
  • Illustrated image demonstrating how the Shockwave Javelin Peripheral IVL Catheter creates a lumen within the vasculature to enable therapy

    Step Four

    Deliver definitive therapy of choice
Shockwave Javelin Peripheral Animation

See Shockwave Javelin in Action

Crack calcium beyond the tip to enable further treatment and expand treatment options across calcified peripheral lesions.

Shockwave Javelin Specifications

Illustration graphic showing the parts of the Shockwave Javelin Peripheral IVL catheter, including details of the emitter, IVL window, catheter shaft and catheter hub
Catalog Number Crossing Profile (mm) Sheath Compatibility (Fr) Guidewire Compatibility Catheter Working Length (cm) Pulses/Cycle Cycles Pulses (Max)
JVNPIVLF 1.5 5 0.014 150 10 12 120

Forward PAD IDE/Feasibility Studies

Shockwave Javelin safely and effectively modifies calcium to cross heavily calcified and severely stenosed above-the-knee (ATK) and below-the-knee (BTK) lesions.1, 2

Acute & 30-day Outcomes1,2

Safe & Effective for Crossing Heavily Calcified Lesions & Severely Stenosed Vessels

Statistics Callout

This section presents key statistical information with numbers and descriptions.

  • 93
    %
    Crossing success
  • 95
    %
    Moderate-to-severe calcification

Safe Calcium Treatment Option, Consistent with Commercially Available Balloon-Based IVL with Low Rates of Angiographic Complications & Major Adverse Events (MAE)

Statistics Callout

This section presents key statistical information with numbers and descriptions.

  • 1.2
    %
    Post-Shockwave Javelin serious angiographic complication rate
  • 4.1
    %
    Post-dilation serious angiographic complication rate
  • 1.0
    %
    Final serious angiographic complication rate
  • 1.1
    %
    MAE at 30 days

Effective Calcium Treatment Option, Consistent with Commercially Available Balloon-Based IVL with Similar Diameter Stenosis Reduction

Statistics Callout

This section presents key statistical information with numbers and descriptions.

  • 83
    %
    Pre-procedure diameter stenosis
  • 59
    %
    Post-Shockwave Javelin diameter stenosis
  • 31
    %
    Post-dilation diameter stenosis
  • 23
    %
    Final diameter stenosis

12-month Outcomes5

At one year, procedures performed with Javelin IVL demonstrated lasting durability, with most patients remaining free from repeat intervention. From procedure to 12-month follow up, procedures utilizing Javelin IVL demonstrated a consistently favorable safety profile, with excellent procedural data at 30 days and very low rates of limb loss and cardiovascular death through 12 months, even in a complex PAD population.

Statistics Callout

This section presents key statistical information with numbers and descriptions.

  • 85
    %
    Freedom from CD-TLR
  • 3.9
    %
    Cardiovascular death
  • 1.0
    %
    Unplanned target limb major amputation

Shockwave Javelin Case Reviews

Explore Education Library

Shockwave Javelin Peripheral Resources

Explore All Products

*Internal testing shows a spherical sonic output from distal emitter consistent with previous Shockwave balloon-based IVL emitters, with sonic output extending beyond the tip of the catheter.
†Internal testing shows a spherical sonic output from distal emitter consistent with previous Shockwave balloon-based IVL emitters.

1: Corl JD, Clair D, Mwipatayi P, et al. FORWARD PAD IDE/Feasibility Studies: Primary Endpoint Analysis of a Novel Non- Balloon-Based Peripheral IVL Catheter. JACC: Cardiovascular Interventions. Published online November 4, 2024. doi:10.1016/j.jcin.2024.10.035.
2: Corl J, VIVA Late Breaking Clinical Trial 2024.
3: Tepe, Gunnar et al. Intravascular Lithotripsy for Peripheral Artery Calcification: Mid-term Outcomes From the Randomized Disrupt PAD III Trial. Journal of the Society for Cardiovascular Angiography & Interventions, Volume 1, Issue 4, 100341. July-August, 2022.
4: Armstrong EJ, Adams G, Soukas PA, et al. Intravascular Lithotripsy for Peripheral Artery Calcification: 30-Day Outcomes From the Disrupt PAD III Observational Study. Journal of Endovascular Therapy. 2024;0(0). doi:10.1177/15266028241283716.
5: Holden A, VIVA 2025.